Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA_PT_OT_Guide_9_2018_DT
CMTA and ToolGen Announce CMT1A Collaboration
CMTA and ToolGen Announce Collaboration to Develop Potential Treatment for CMT1A Using Gene Therapy (Glenolden, PA, October 7, 2021) The Charcot–Marie–Tooth Association (CMTA), the largest philanthropic funder of CMT research…
CMTA_PT_OT_Guide_9_2018_DT
CMTA Grassroots Events
At the CMTA, our vision is a world without CMT. Our mission is to support the development of new drugs to treat CMT, to improve the quality of life for…
CMTA-STAR Alliance Partner Actio Biosciences Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Their Treatment in Development for CMT2C
…designation (RPDD) designation from the FDA for ABS-0871, a TRPV4 inhibitor for treating CMT2C. This achievement represents a crucial step forward for CMT2C patients and the CMT community. “We are…
Disability for CMT Peripheral Neuropathy: VA & Social Security
How likely are people with CMT to get Social Security disability benefits the first time they apply? Many people believe that it is very difficult to get disability benefits from…
Balance Walking Stick Exercises for CMT
The Balance Walking for CMT Video Series demonstrates how using balance walking poles or walking sticks for balance can dramatically increase the confidence, fitness and mobility of people living with…
Faces of CMT Photography Competition
…living with CMT and strategies to overcome them.” This is an international competition open to everyone! Whether you’re living with, or alongside CMT, this is an opportunity to share your…
CMTA-STAR Alliance Partner Begins Clinical Trial in CMT2S
…of CMT, including rare subtypes like CMT2S. We are proud to partner with CMTA-STAR Alliance Partner Vanda Pharmaceuticals as they advance this precision-driven program. CMTA Strategy to Accelerate Research (CMTA-STAR)…